Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H25N3O3 |
Molecular Weight | 379.4522 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=CC=C1N2CCN(CCC3=CNC4=CC5=C(OCO5)C=C34)CC2
InChI
InChIKey=GIWODWVYEOAGQV-UHFFFAOYSA-N
InChI=1S/C22H25N3O3/c1-26-20-5-3-2-4-19(20)25-10-8-24(9-11-25)7-6-16-14-23-18-13-22-21(12-17(16)18)27-15-28-22/h2-5,12-14,23H,6-11,15H2,1H3
Molecular Formula | C22H25N3O3 |
Molecular Weight | 379.4522 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5919502
Curator's Comment: Solypertine selectively blocked the conditioned avoidance response in rats. Solypertine potentiated hexobarbitone sleeping time, caused hypothermia and afforded protection from amphetamine toxicity inaggregated mice.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5919502
Mice: LD50 = 81.5 mg/kg.
Solypertine (WIN-18413-2) in doses of 4 and 8 mg/kg, caused behavioural depression and apathy in the cats.
Route of Administration:
Intraperitoneal
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:26:41 GMT 2025
by
admin
on
Mon Mar 31 19:26:41 GMT 2025
|
Record UNII |
9BUF6DCO0C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66883
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
||
|
NCI_THESAURUS |
C29710
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9BUF6DCO0C
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
PRIMARY | |||
|
20517
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
PRIMARY | |||
|
DTXSID50196189
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
PRIMARY | |||
|
100000084044
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
PRIMARY | |||
|
SUB10577MIG
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
PRIMARY | |||
|
CHEMBL1739674
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
PRIMARY | |||
|
4448-96-8
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
PRIMARY | |||
|
C152390
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
PRIMARY | |||
|
1327
Created by
admin on Mon Mar 31 19:26:41 GMT 2025 , Edited by admin on Mon Mar 31 19:26:41 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |